TFE3 and cancer: Importantly, our current studies provide evidence that the PP2A-TFE3-ATF4 axis is a molecular process essential to dictate ISR plasticity, supporting a promising avenue for cancer-selective therapies based on manipulating PP2A-mediated irreversible ISR, while also providing novel insight into DT-061’s antitumor properties.